Sienna Biopharmaceuticals, Inc.

CIK 1656328 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Sienna Biopharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Feb 14, 2020SC 13G/A0001104659-20-021670
Feb 7, 2020SC 13G/A0000315066-20-001212
Feb 5, 202025-NSE0001354457-20-000059
Dec 16, 2019EFFECT9999999995-19-002814
Dec 11, 201915-12B0001193125-19-311597
Dec 11, 2019S-8 POS0001193125-19-311524
Dec 11, 2019S-8 POS0001193125-19-311554
Dec 11, 2019S-8 POS0001193125-19-311517
Dec 11, 2019POS AM0001193125-19-311570
Dec 11, 20198-K0001193125-19-310663
Nov 15, 20198-K0001193125-19-292919
Nov 12, 201910-Q0001193125-19-290017
Oct 17, 20198-K0001193125-19-268976
Oct 4, 201940001562180-19-005117
Sep 23, 20198-K0001193125-19-251555
Sep 17, 20198-K0001193125-19-246310
Aug 14, 20198-K0001193125-19-221192
Aug 8, 201910-Q0001193125-19-216859
Aug 8, 201940001562180-19-004216
Aug 8, 201940001562180-19-004218
Aug 8, 201940001562180-19-004219
Aug 8, 201940001562180-19-004217
Jul 3, 201940001562180-19-003848
Jul 3, 201940001562180-19-003852
Jul 3, 201940001562180-19-003850